Compounded tirzepatide
Sold by ARSYNL Rx · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
Recorded initial charges
First month
$256.33
first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.
| Medication · Tirzepatide HypoSpray (transdermal, needle-free) · recorded initial monthly payment | $256.33 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Tirzepatide HypoSpray (transdermal, needle-free) “Compounded Tirzepatide HypoSpray® Therapy FROM: $256.33 / month” | Per month$256.33 | Charged today$256.33 |
Price sources
- Tirzepatide HypoSpray (transdermal, needle-free) · arsynl.com — read September 2026
We earn nothing from this link. It opens ARSYNL Rx's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | The Pharmacy Hub; Chemistry Rx; Vital Rx; Optimal Balance Pharmacy; Center City Pharmacy; Olympia Pharmacy |
|---|---|
| Prescriber | Both |
| Cancellation | How do I reorder or cancel? Login to your Arsynl account and reorder or cancel at any time. You will be contacted before your medication is to be refilled and billed to your credit card. |
Not yet checked: states, membership and consult fee.
Recorded from arsynl.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Tirzepatide is sold in two formats: a standard injectable at $233/mo and a needle-free transdermal 'HypoSpray' at $256.33/mo. The HypoSpray's delivery method (a metered transdermal spray) does not match any of the schema's form options (not an injection, oral tablet, or sublingual placement), so it was recorded as not-disclosed with this note. Neither injectable product page states vial vs. pen.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.